Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study

BACKGROUND: Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Marković, Danica, Jevtović-Stoimenov, Tatjana, Ćosić, Vladan, Stošić, Biljana, Dinić, Vesna, Marković-Živković, Bojana, Janković, Radmilo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294091/
https://www.ncbi.nlm.nih.gov/pubmed/30581346
http://dx.doi.org/10.1515/jomb-2017-0046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294091/
https://www.ncbi.nlm.nih.gov/pubmed/30581346
http://dx.doi.org/10.1515/jomb-2017-0046

Ejemplares similares